IL33 and Alzheimer disease: Additionally, resveratrol has been shown to ameliorate histological changes in AD-like lesions by reducing epithelial thickness and expression of proinflammatory cytokines such as IL25, IL33, and thymic stromal lymphopoietin (TSLP), while also decreasing epithelial apoptosis.